Notice of Intent to Sole Source; Siemens Medical Solutions
| Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
|---|---|
| State: | Maryland |
| Type of Government: | Federal |
| FSC Category: |
|
| Posted Date: | Oct 26, 2024 |
| Due Date: | Nov 15, 2024 |
| Solicitation No: | 25-000068 |
| Original Source: | Please Login to View Page |
| Contact information: | Please Login to View Page |
| Bid Documents: | Please Login to View Page |
Description
- Contract Opportunity Type: Special Notice (Original)
- Original Published Date: Oct 25, 2024 04:53 pm EDT
- Original Response Date: Nov 15, 2024 10:00 am EST
- Inactive Policy: 15 days after response date
- Original Inactive Date: Nov 30, 2024
-
Initiative:
- None
- Original Set Aside:
- Product Service Code: 6515 - MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES
-
NAICS Code:
- 513210 - Software Publishers
-
Place of Performance:
Bethesda , MDUSA
The purpose of this acquisition is to acquire support and maintenance for our existing Syngo Dynamics application.
• Product Service Code: 6515 – Medical Instruments, Equipment, and Supplies
• NAICS Code: 513210 – Software Publishers
• Place of Performance: Bethesda, MD 20892 USA
POTS: 25-000068
Description:
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.
The National Institutes of Health (NIH) intends to award a fixed price purchase order to Siemens Medical Solutions located at 40 Liberty Blvd, Malvern, PA 19355, on a firm fixed price sole source award basis to provide Syngo Dynamics software maintenance agreement to the National Institutes of Health.
Below is a description of the item(s):
Description: Syngo Dynamics Application and Support
Catalog #: SYNDSWSUPPORT
Units: Each
Quantity: 1
This acquisition is to activate software maintenance and support service agreement for the Siemens’ Syngo Dynamics General Ultrasound software package. Syngo Dynamics software is proprietary software licensed and manufactured by Siemens Medical. It will be in daily use by the RAD&IS for critical patient care.
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.
Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by November 15th, 2024 at 10am EST.
- 6707 DEMOCRACY BLVD, SUITE 106
- BETHESDA , MD 20892
- USA
- Kristin Nagashima
- kristin.nagashima@nih.gov
- Oct 25, 2024 04:53 pm EDTSpecial Notice (Original)
See Also
Follow Single cell methylation Active Contract Opportunity Notice ID 75N98026Q01085 Related Notice Department/Ind.
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Due by 9/20/2026
Follow Specialized Blood Products-AABB Active Contract Opportunity Notice ID 26-008618 Related Notice Department/Ind.
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Due by 9/20/2026
Follow Electrosurgical unit (ESU) Active Contract Opportunity Notice ID 75F40126Q00277 Related Notice Department/Ind.
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Due by 9/16/2026
Follow NOTICE OF INTENT TO SOLE SOURCE - PROCUREMENT OF THE BIO-RAD CHEMIDOC
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Due by 9/18/2026